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Abstract 
Studies of severe, monogenic forms of language disorders have revealed important insights into the 
mechanisms that underpin language development and evolution. It is clear that monogenic mutations 
in genes such as FOXP2 and CNTNAP2 only account for a small proportion of language disorders 
seen in children, and the genetic basis of language in modern humans is highly complex and poorly 
understood. In this review, we examine why we understand so little of the genetic landscape of 
language disorders, and how the genetic background of an individual greatly affects the way in which 
a genetic change is expressed. We discuss how the underlying genetics of language disorders has 
informed our understanding of language evolution, and how recent advances may obtain a clearer 
picture of language capacity in ancient hominins.  
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Introduction 
The ease with which most children acquire their native language has lead researchers to propose that 
language acquisition is innate, 1, and suggest that this reflects a genetically determined language-
specific module 2. Others argue that it simply reflects higher order processing in humans and is 
facilitated by their existing cognitive skills 3. Major questions remain as to the evolutionary and 
genetic mechanisms that underpin these proposed models; did language evolution rely upon a small 
number of ‘big-hit’ mutations which rapidly changed cognition, or through a series of small-step 
changes where many variants were accumulated slowly over thousands of years? Did ancient 
hominins have the cognitive ability to use some form of language?  
 
The study of genetic variation that underpins language ability in modern humans can provide insights 
into how higher language function evolved in our ancient ancestors. The application of next 
generation sequencing technology means that we are now able to generate a near-complete picture of 
genetic variation with relative ease. The discovery of genetic variants associated with language 
disorders results in the identification of the genes and molecular pathways necessary for the 
successful acquisition of language. Genetic studies of modern humans, therefore, have direct 
relevance to the study of how language evolved in our ancestors.  
 
Discussion of the evolution of language in fields outside of genetics, still tend to consider ‘a gene for 
language’ as the principle driver of language evolution. While the consideration of single variants and 
genes has provided important insights, the field of human genetics has moved on. Here, we argue that 
in order to understand language evolution, we first need to consider the full genetic landscape in 
modern humans, then use this to inform our understanding of the forces that shaped language 
evolution in ancient hominins.  
 
Language Disorders 
When considering which genetic pathways contribute to language, researchers often choose to study 
the extremes of language ability - most often when a person’s ability to speak is severely impaired. So 
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far, the greatest insights into the molecular biology of language have come from studying the genetics 
of families and individuals with persistent language disorders.  
 
A recent study found that over 7% of British children (n=12,000, Surrey) at school entry had impaired 
language, either as part of a complex developmental disorder such as autism spectrum disorder 
(ASD), developmental delay or intellectual disability, or as a primary language disorder with no other 
explanatory features 4. Previous smaller English speaking studies concluded similar rates 5; 6. In real 
terms, this means that a staggering three children in every class have a language disorder 4. Age 
appropriate language acquisition is so important to a child’s development that receptive language 
ability at age 3 is a predictor of an individuals’ future economic burden 7. Despite educational 
intervention, over half of children with language disorders have lasting difficulties with language 
throughout their childhood 8. This means that a child who struggles to understand or produce 
language, even from an early age, has an increased risk of behavioural disorders, unemployment and 
mental health issues later in life 9. This importance is clearly demonstrated in a recent systematic 
review which found that there was a consistent strong association between young offenders and 
language disorders 10.From a genetics point-of-view, it is of particular interest when language disorder 
occurs in isolation (so-called primary language disorder), with no other features such as autism 
spectrum disorder or developmental delay that may confound difficulties with language. Primary 
language disorders may represent domain independent deficits and therefore provide an excellent 
opportunity to study the genetics that underpin speech.   
 
Two such primary language disorders are childhood apraxia of speech (previously called 
developmental verbal dyspraxia) (CAS, OMIM #602081) and developmental language disorder 
(DLD) (also known as specific language impairment) (SLI, OMIM %606711, %606712, %607134, 
%612514). Although both conditions are primary language disorders, they are proposed to arise from 
different obstacles in language production pathways. CAS is primarily a motoric difficulty in which 
the brain cannot coordinate the fine muscles controlling the tongue, lips and mouth that are required to 
produce speech 6. DLDs are a persistent difficulty with more generalised aspects of speech and 
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language, in the absence of any other explanatory medical condition such as hearing difficulties or 
developmental delay 11. The diagnostic guidelines for DLDs are therefore less stringent than CAS and, 
accordingly, DLDs are an extremely common childhood developmental issue that can persist 
throughout the child’s life. In this review we will focus on the primary language disorders DLD and 
CAS. 
 
There is little doubt as to the impact of language disorders on children, but despite the frequency and 
impact on society, we still understand little of the underlying neurobiology. It is clear that the risk of 
speech and language disorder is increased if a parent or sibling has a speech disorder 12. Many studies 
indicate that language ability is highly heritable, and that that genetic factors play a role in this 
familiality 12-14. The identification of genetic variants or risk factors for DLDs may explain why some 
children struggle with language acquisition. It may also help explain why language ability is so often 
affected in related disorders such as ASD, developmental dyslexia, intellectual learning disability or 
attention deficit hyperactivity disorder (ADHD) and tease apart the phenotypic overlaps between 
these highly related disorders. Assuming that language impairments are at one end of a continuum of 
language ability, genetic studies are providing a better understanding of the molecular pathways that 
are important in language acquisition. 
 
Genes Involved in Disorders of Language Development 
When a language disorder recurs within multiple generations of a family, we often assume a strong 
genetic contribution. Such families have therefore traditionally been the obvious place to start when 
studying genetic inheritance. The principal insights into the genetics of DLDs have come from such 
family studies, and several genes have been identified using genetic linkage and candidate gene 
sequencing in related family members (Table 1). These genes were often identified from single 
families or a number of related individuals, using genetic linkage to look for regions of the genome 
shared by language impaired family members, or by testing for genetic association between large 
numbers of unrelated individuals with a similar phenotype (Table 1). Genetic linkage and association 
approaches have traditionally been the mainstay of neurodevelopment genetics, with much success.    
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The most successful study in this field, to date, has been the identification of an arginine to histidine 
mutation at amino acid position 553 (denoted as p.R553H) in the FOXP2 gene, identified in a large, 
multigenerational family known as the KE family. Family members who carry this mutation have the 
CAS phenotype 15. In genetic terminology, the p.R553H change is a dominant, fully penetrant 
mutation – one mutated copy of the gene is enough to result in a particular disorder. Fully penetrant 
cases are rare and presumably differ from more ‘typical’ cases of DLD, where one genetic change 
cannot be directly correlated with their disorder. While this remains the most studied and best 
characterised gene implicated in speech, mutations in FOXP2 only account for about 2% of CAS 
cases 16, and as such, causative mutations in FOXP2 are still considered a rare cause of language 
disorders.  
 
FOXP2, dubbed a ‘molecular window’ into speech and language development, has been a leap-pad 
for the identification of other genes and mechanisms involved in language (for example, CNTNAP2 17, 
as described below). The discovery of FOXP2 was hailed by the media as the ‘speech gene’ – 
suggesting that this single protein is responsible for language development in humans. This headline 
tag is an overly simplistic interpretation, which has endured in fields outside of genetics and language 
biology. More recently, investigation into the molecular function of FOXP2 has slowly built a more 
detailed picture of its role in language development 18-20. The literature is clear – FOXP2 is not the 
sole explanatory factor for presence of language.  
 
Table 1 – Major genes implicated in language disorders, and associated overlapping 
phenotypes. The table shows genes from association or linkage of language disorders, and does not 
include a thorough review of other phenotypes (dyslexia, ASD etc). * indicates gene has been 
reported as monogenic. 
Gene Associated Disorder(s) Key References 
ABCC13 Language disorder 21 
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ARHGEF39 Language disorder 22 
ATP2C2 Language disorder (short term memory) 23; 24 
BCL11A Language disorder (specifically CAS) with expressive language 
and mild intellectual delay 
25 
CMIP Language disorder (short term memory) 
Language disorder and dyslexia 
Dyslexia 
23 
26 
27 
CNTNAP2 Language disorder 
Autism 
17 
28; 29 
DCDC2 Dyslexia 
Language disorder and dyslexia 
30; 31 
27; 32; 33 
ERC1 Language disorder (CAS) 34; 35 
FLNC Language disorder and reading difficulties 36 
FOXP1* Language disorder and intellectual delay 37-41 
FOXP2 * Language disorder (specifically CAS) 15; 42-46 
GRIN2A Focal epilepsy with speech disorder, with or without mental 
retardation 
35; 47-49 
KIAA0319 Dyslexia 
Language disorder 
27; 50 
26 
NDST4 Language disorder 51 
NFXL1 Language disorder 52 
NOP9 Language disorder 53 
RBFOX2 Language disorder and reading difficulties 36 
ROBO1 Dyslexia 
Language disorder and dyslexia 
54 
55 
ROBO2 Language disorder 56 
SETBP1 Language disorder 57-59 
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SRPX2  Language disorder, rolandic seizures and intellectual delay 35; 60 
TM4SF20 * Language disorder 61 
 
There are very few instances of monogenic inheritance, where the absence of a protein leads directly 
to language disorder. In Table 1, only FOXP2, FOXP1 and TM4SF20 have been described as 
monogenic drivers of language disorders. The remainder of the identified genes instead confer risk of 
language disorder through genetic variations that subtly alter the way in which genes and proteins 
work. The majority of genes have been implicated in language disorders through association with 
language-related phenotypes obtained from cohort studies. In contrast to FOXP2, where a mutation 
explains the observed language difficulties (monogenic model), these genes tend to play a role within 
a complex genetic model. Carrying a risk variant within these genes confers a ‘susceptibility’ to 
develop language disorder, however this remains difficult to quantify and is poorly understood. 
Nonetheless, the study of cases and their families has provided an important window into the 
underlying mechanisms of language disorders. At present, FOXP2 and FOXP1 remain the best 
characterised of the genes implicated in language disorders. Clinical diagnosis of the underlying 
molecular cause of a language disorder is not usually possible, unless the causative mutation is within 
FOXP2, FOXP1 or TM4SF20. Mutations in these genes are rare, and therefore the majority of 
language disorder cases are unlikely to have an underlying molecular cause identified. 
 
Large scale genome sequencing projects such as 1000 Genomes 62 and ExAC 63 have created a major 
shift in how we perceive human genetic variation and its contribution to disease. We have understood 
for decades that monogenic disorders usually involve rare mutations which impact upon the function 
of the protein. Such mutations usually lead to non-functional proteins which manifest in a disease 
phenotype. Access to large numbers of control genomes through 1000 Genomes and ExAC has 
enabled us to more accurately identify and assess genetic risk factors, which tend to be more common 
in the population, but may confer a modest risk of developing a phenotype.  
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These databases also provide unprecedented power to inform our understanding of gene function in 
modern humans, and by proxy, our ancestors. It is well established that Neanderthals and Denisovans 
shared the ‘humanised’ version of FOXP2, which differs from ancestral FOXP2 at two positions; 
chromosome 7, base-pair 114,282,597 (denoted as chr7:114,282,597) resulting in an arginine rather 
than the ancestral threonine at position 303 (denoted as p.N303) and chromosome 7, base-pair 
114,282,663 (denoted as chr7:114,282,663) resulting in a serine at amino acid position 325 rather than 
the ancestral arginine (denoted as p.S325) (variant 1, hg19) 64. This important finding gave rise to the 
idea that Neanderthals may have had a sophisticated level of cognitive processing to support some 
form of language 64. 
 
Interestingly, the ‘humanised’ FOXP2 amino acid at position 325 is somewhat called into question by 
the presence of two apparently healthy controls in the ExAC database. These two individuals carry 
one copy (heterozygous) of a T>G change at neighbouring position (chr7:114,282,664), essentially 
reverting the amino acid sequence to the ancestral form, resulting in a serine to arginine change 
(p.S325N). This change is extremely rare (allele frequency=0.00001648) and only seen in 2 of more 
than 60,000 individuals, but it poses the question - did these apparently healthy individuals have 
language difficulties? Although ExAC participants were not specifically screened for cognitive 
function or language ability, it is unlikely that they had an overt phenotype as this would have 
excluded them from the study. This presents an interesting line of thought, that if these two amino 
acids are the hominin form of FOXP2, then there are at least two functioning humans out there who 
do not have a fully ‘humanised’ version of FOXP2. The presence of a non-human FOXP2 amino acid 
change in these two healthy individuals shows the power of these databases to identify extremely rare 
occurrences of a variant carried in less than 0.0016% of the population. It provides a more accurate 
snapshot of human variation with which we can more effectively predict which variants are likely to 
be important.  
 
Even in monogenic disorders, when it is clear that the trait is directly caused by a dominant mutation, 
we still observe a high degree of variability between individuals (incomplete penetrance). Such 
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phenotypic variability is even present within the KE family who have a ‘fully’ penetrant dominant 
FOXP2 mutation with a clear-cut phenotype 15; 65. It is widely reported that some individuals of the 
KE family present with non-verbal difficulties. The performance IQ scores of five affected KE family 
members are varied - on male affected (age 10) scored 112 compared to a second 10 year old affected 
male who scores 66. These individuals carry the p.R553H mutation which explains their CAS 
phenotype, but the differences in performance IQ are likely due to genetic modifiers, and not directly 
related to FOXP2. , For the majority of language disorder loci discovered to date, it is likely that they 
explain only part of the risk and the modifier, and additional variants have yet to be identified. We are 
only just beginning to understand the actions of modifiers and risk factors, but this concept underlies a 
shift from the traditional genetic model, in which phenotypes are truly dominant or recessive. Instead 
we now understand the importance of considering all variation on a genetic background.  
 
Complex Inheritance and Genetic Risk 
The power of familial studies are a proven method to identify contributory genes, but increasingly 
molecular genetics is focussing on the role of modifiers and risk factors in DLDs. The majority of 
genes listed in Table 1 that have been associated with language disorders fall into this category. An 
example is an asparagine to lysine change at amino acid position 150 (denoted as p.N150K) in the 
NFXL1 gene. This variant (rs144169475), identified by sequencing five affected Islanders, was found 
to be associated with language impairment on Robinson Crusoe Island, an isolated Chilean population 
with an exceptionally high rate of language disorders 52. This variant likely forms a key part of a 
complex inheritance model where a single variant only explains part of the DLD risk. The variant is 
seen in 4.1% in South American control genomes, and is therefore considered common in Latin 
America, suggesting that it may confer susceptibility to DLD when inherited in combination with 
other variants that are yet to be identified.  
 
The study of complex genetic factors is primarily performed using large numbers of unrelated cases 
specifically selected to have a high degree of phenotypic similarity. Large scale genome-wide 
association studies (GWAS) with several thousands of participants may be able to successfully 
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identify common risk variants involved in DLDs, however a large scale study of this nature has not 
yet been attempted. A recent GWAS into the genetic basis of schizophrenia successfully identified 
more than 100 associated loci using 37,000 schizophrenia patients and 113,000 controls 66. The 
application of these methods in clinical traits such as schizophrenia, have shown that enormous 
sample sizes are required to enable the consistent replication of associated loci.  
 
A major limiting factor in performing a large scale GWAS for language disorders remains the 
systematic phenotyping of enough participants to gain the statistical power required to detect 
contributory variants. This challenge is common to most large complex genetics studies, but is 
particularly pronounced for the field of language disorders where there is little consensus on what 
constitutes a speech and language disorder, or how it should be diagnosed and classified. A recent 
report by the CATALISE consortium aims to do exactly that 11. Even the terminology used to describe 
language disorders and DLDs required standardisation across disciplines, and although these are the 
current approved terms, they are taking time to become standard in research and education. 
Establishing consistent terminology is the keystone to developing standardised diagnostic criteria. 
Once these definitions are consistent within and across disciplines, then a large scale study could be 
successfully developed. It would likely lead to the identification of a novel pathways and gene 
networks involved in language production.  
 
Table 1 reveals the striking number of genes implicated in DLDs which are also implicated in other, 
closely related neurodevelopmental disorders. Vernes and colleagues identified an association 
between variants in the contactin-associated protein like 2 gene CNTNAP2 and DLDs through its 
interaction with the transcription factor FOXP2 17. Variants in CNTNAP2 are also associated with 
ASD 28; 67, cortical dysplasia focal epilepsy syndrome (OMIM #610042) 68, and Pitt-Hopkins-like 
syndrome (OMIM #610042) 69. Another example of genes implicated in language overlapping with 
related disorders is the axon guidance receptor protein ROBO1. It was first implicated as a candidate 
gene for dyslexia in a patient with a translocation involving the ROBO1 region 54, and was 
subsequently found to be associated with short term memory of words, a key feature of DLD 55. Other 
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examples of genes involved in language disorders that overlap with a dyslexia phenotype, include 
DCDC2, KIAA0319 and CMIP 27; 30 .  
This observation suggests the documented phenotypic overlap between developmental disorders like 
DLD, ASD, and dyslexia may be driven by shared genetic aetiology. We should note, however that 
the level of shared aetiology is hard to objectively ascertain without genome-wide data. Technical and 
financial limitations mean that many studies of DLDs to date are limited to candidate genes, leading 
to substantial ascertainment bias. 
The factors that determine how a given genetic variant manifests to become one phenotype over 
another is not fully understood, but they are likely to involve interactions between genetic variants.  
This emphasises the need to consider the genetic background of an individual within any candidate 
gene analyses. These multiple layers of complexity partly explain why genetic studies have so far 
struggled to elucidate the genetic basis of many neurodevelopmental disorders.   
 
Limitations of current genomic studies 
There are a number of reasons why we do not have a better picture of the genetics of speech and 
language disorders. As discussed above, the majority of studies have used relatively low resolution 
mapping methods within small sample sizes with inconsistent characterisation between studies. 
Recent advances in DNA sequencing technology allow us to generate a more complete picture of 
genetic variation across the entire genome (whole genome sequencing) or across all known genes in 
the genome (whole exome sequencing). Whilst such technologies afford better resolution and, to some 
extent, offset these problems, the identification of risk variants, which only have a small effect size, 
remain difficult.  
 
The average human genome contains between 4 and 5 million variants that differ from published 
reference sequences. Only about 1% of the human genome actually encodes genes, and these gene 
encoding regions will contain about 150 coding mutations which result in the loss-of-function of the 
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protein. They will also contain around 10,000 ‘silent’ mutations that fall within genes but do not alter 
the amino sequence. Each person’s genome will contain about 120 novel coding variants which have 
not previously been reported 62. The vast majority of variation we see in the human genome does not 
directly change the protein, and is non-coding. Once we consider that these non-coding changes may 
have a function affecting gene expression (how much of each protein is made), the list of potential 
variants can be vast, and extremely challenging.  
 
Exome sequencing studies investigate just the coding regions of the genes of individuals affected by 
DLD 35; 59 or CAS 16. These preliminary, small-scale investigations confirm the complexity of the 
underlying genetics in the majority of cases and reinforce the need for larger-scale screening studies.    
 
Even though they lie outside of gene sequences, non-coding variants can change gene functions, for 
example by increasing or decreasing expression. It is highly likely that these non-coding variants will 
be involved in neurodevelopmental disorders. These variants represent a far greater challenge than 
coding variants. They are often not captured by whole exome sequencing meaning that we may 
simply be missing important mutations. Whole genome sequencing is becoming more commonly 
used, but cost is often prohibitively expensive. Even when these variants are captured, their 
categorisation is difficult. A recent study demonstrated a role for variations within non-coding 
regulatory regions in DLD and other neurodevelopmental conditions underlining the importance of 
this route of investigation 22. The use of whole genome sequencing produces vastly more data, and 
analysis can be more computationally expensive, and requires a much greater level of analytical 
expertise. Since the effects of these variants are often indirect, their characterisation usually involves 
complex functional validation steps that are challenging to complete for a high number of variants.  
 
Genetic studies tend to be performed on European or American cohorts. Findings in these participants 
may not be relevant in other populations as some variants can be more or less common in a different 
population, and different groups may need their own specific studies to gain a better global 
understanding. For example, the NFXL1 variant found to increase risk of DLD on Robinson Crusoe 
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Island was found in 4.1% of Latin Americans, but 0% of Europeans 52. Similarly, investigations of an 
isolated Russian population have yielded novel loci in relation to DLD 59. The availability of 1000 
Genomes data has improved power to detect variants that differ in allele frequencies between 
populations however, these are still limited to relatively small numbers of individuals from a restricted 
set of countries.  
 
Another degree of complexity is added by tissue specificity; while present in the genomic DNA of 
every cell, some mutations may only have a detectable effect in a specific tissue, at a particular time 
in development. The function of a gene can vary between cell types and conditions, and many genes 
have multiple, and often surprisingly different, functions. FOXP2 is highly expressed in the brain, but 
is also highly expressed in the lungs and many other tissue types all of which will carry the mutation 
at a DNA level 70. The brain appears particularly sensitive to this particularly change and, as far as we 
are aware, the lungs of the KE family are unaffected 15. It is therefore important to remember that 
although genomic technologies can give us a window into what is happening in a particular 
individual, it is far more challenging to predict the cellular context in which it will become important. 
 
Paleogenetics and Language 
In evolutionary terms, the window to understand genetic effects on cognitive function and language 
ability in hominins is even narrower than in modern humans, and must be interpreted with extreme 
caution. The humanised version of FOXP2 is thought to have become fixed in the population around 
500 KYA, prior to the last shared common ancestor (370-450 KYA) 71 and the presence of this 
version in Neanderthals supports the notion of cognitive function sophisticated enough to support 
language. More recently, a regulatory region of FOXP2 was identified exclusively in modern humans 
at a binding site of the transcription factor POUF3F2 which is absent in Neanderthals 72. This 
suggests that differences in gene regulation and expression may be involved in cognitive function, and 
that species differences are due to far more than just two variants in a single gene. We must be 
cautious when interpreting such information as it is extremely unlikely that these FOXP2 changes are 
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solely responsible for the presence (or absence) of language function, and any observations, modern 
or otherwise, should consider the entire genetic background. 73 
 
To further complicate the underlying assumptions in evolutionary studies, the small numbers of 
Neanderthals sequenced heavily biases the study findings. The difficulties in obtaining ancient DNA 
of suitable quality for sequencing, means that sequenced individuals are not representative of time 
periods or geographical locations, and are from a small number of sites where preservation conditions 
were optimal. As discussed above, genome sequence studies clearly illustrate that small numbers of 
individuals from one or two geographical locations do not represent the entire population. This is the 
modern genetic equivalent of sequencing one family and assuming that everyone else is the same – 
this is not genetically plausible. There is not enough available population data to be able to accurately 
predict genetic affects, particularly with respect to complex cognitive processes like language 
function.  
 
Paleogenetics researchers are slowly building a broader and more accurate picture of ancient hominin 
genetics through sequencing larger numbers from a range of geographical locations. A larger sample 
size will greatly improve the statistical significance of findings, and increase confidence in their 
implication for language and higher cognitive function. Genes that are implicated in language 
disorders in modern can inform investigation of language in ancient hominins, and there have been 
several efforts to investigate the impact of language associated genes more broadly 73. Through the 
expansion of genetic technologies and a greater understanding of their application and limitation, we 
will continue to build a more accurate picture of both modern and ancient language cognition slowly, 
piece by piece, applying the scientific rigour and multiple lines of evidence of molecular biology.  
 
Discussion 
The study of language disorders has been fruitful in implicating genes, and subsequent molecular 
pathways that are involved in the mechanisms of language. While there have been many exciting 
discoveries spanning the past two decades, there remains much more to understand. We still do not 
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fully understand the underlying causes of DLDs, and what makes some children are more susceptible. 
Family studies can still provide novel insights into the underlying mechanisms of DLDs. There is 
strong potential for using a familial shared genetics-based approach, particularly when combined with 
recent advances in sequencing technologies that can investigate more of the genome than ever before.. 
We increasingly recognise that genetic risk plays a key role in language disorders and many current 
approaches are investigating a genetic background of susceptibility. To be statistically sound, these 
studies require much larger sample sizes and more consistently phenotyped datasets to generate 
sufficient statistical power. The reality is that DLDs are likely to involve some high impact rare 
mutations, genetic rearrangements and common sequence variations, all of which create a background 
of susceptibility. Family based and association studies are still uncovering some unlikely pathways 
which play a role in language disorders, and it is clear that it will not be a simple story.  
 
The idea that a single gene has a distinct role or confers a single trait is an outdated concept. 
Similarly, the idea that a gene will have a single role in the cell has been dispelled. We understand 
that non-coding variants can play a crucial role in gene regulation, and are highly likely to have an 
important function in DLDs, and other neurodevelopmental disorders. The genetic background and 
regulation of gene expression and function is dynamic, and depends greatly on individual cell types. 
While this is still poorly understood, methods for detecting and experimentally validating such 
context dependent states are in development. The function of a gene in a particular cellular 
circumstance can, and will be validated by molecular biology in model animal or cellular systems. 
Genetic control is no longer beyond our testing capability, and we have a range of technologies to 
characterise gene function and expression across different cell types and under different conditions. 
 
Environmental factors clearly play a role in language development, and poor life circumstance may 
impact the DLD phenotype. Nature versus nurture is a falsely binary concept, and the underlying 
genetics plays a key role within an environmental (nurture) context. 
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The theory that the presence of ‘humanised’ FOXP2 gene in Neanderthals drove language ability is 
naive and overly simplistic. FOXP2 clearly plays an important role in speech evolution and 
production, however, we must be cautious to avoid making over-inflated statements about language in 
Neanderthals based on a single gene 19. We are only just beginning to unravel the highly complex 
developmental processes that underlie speech in modern humans, and should be extremely cautious in 
extrapolating any findings into hominins. The identification of risk factors for DLDs in modern 
humans will inform our understanding of capacity for language in ancient hominins. We may be able 
to build a far clearer picture of how language evolved once we increase our understanding of the 
neuromolecular pathways involved language development in modern humans.  
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